In tumors with normal distribution of TIL, the cytotoxic effect of T lymphocytes in vivo can be restored by downregulating the expression of PD‐L1 in EGFR‐TKI drug‐resistant lung cancer. The gene discussed is EGFR; the disease is lung cancer.